KLRG1 marks tumor-infiltrating CD4 T cell subsets associated with tumor progression and immunotherapy response.
Ager CR, Zhang M, Chaimowitz M, Bansal S, Tagore S, Obradovic A, Jugler C, Rogava M, Melms JC, McCann P, Spina C, Drake CG, Dallos MC, Izar B.
Ager CR, et al. Among authors: jugler c.
J Immunother Cancer. 2023 Sep;11(9):e006782. doi: 10.1136/jitc-2023-006782.
J Immunother Cancer. 2023.
PMID: 37657842
Free PMC article.